The Chemours Co (NYSE:CC)
$ 28.83 0.37 (1.3%) Market Cap: 4.29 Bil Enterprise Value: 7.78 Bil PE Ratio: 0 PB Ratio: 5.71 GF Score: 78/100

Q4 2023 Chemours Co Earnings Call Transcript

Mar 28, 2024 / 12:00PM GMT
Release Date Price: $26.26 (-9.07%)
Operator

Good morning. My name is Sarah, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company Fourth Quarter and Year-End 2023 Results Conference Call.

(Operator Instructions)

I would like to remind everyone that this conference call is being recorded. I would now like to hand the conference call over to Brandon Ontjes, Vice President of FP&A and Investor Relations for Chemours. You may begin your conference.

Brandon Ontjes
The Chemours Company - VP of FP&A and IR

Good morning, everybody. Welcome to The Chemours Company's Fourth Quarter and Year-End 2023 Earnings Conference Call. I'm joined today by Denise Dignam, Chemours' Chief Executive Officer; and Chemours' Interim Chief Financial Officer, Matt Abbott.

Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties as described in Chemours' SEC filings.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot